| Kristen Talbot, PHARM D | |
|
101 Chesnut Byp, Centre, AL 35960-1427 | |
| (256) 927-4346 | |
| Not Available |
| Full Name | Kristen Talbot |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 101 Chesnut Byp, Centre, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679940357 | NPI | - | NPPES |
| 15953 | Other | AL | STATE LISCENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15953 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Talbot, PHARM D 5090 Hidden Point Dr, Cedar Bluff, AL 35959-5095 Ph: (256) 393-2271 | Kristen Talbot, PHARM D 101 Chesnut Byp, Centre, AL 35960-1427 Ph: (256) 927-4346 |
News Archive
Researchers at St. Michael's Hospital working in conjunction with EMS services, paramedics and fire services across Ontario found that a bystander who attempts cardiopulmonary resuscitation (CPR) can quadruple the survival rate to over 50 per cent. But Dr. Laurie Morrison and the research team at Rescu (www.rescu.ca) have found only 30 per cent of bystanders in Toronto are willing to help, one of the lowest rates of bystanders helping others in the developed world.
In a decision of importance to the case at hand and all cases involving claims of attorney-client or work product privilege, the Honorable Cynthia M. Rufe of the United States District Court for the Eastern District of Pennsylvania, in a decision of December 7, 2009, has ruled that GlaxoSmithKline (GSK), the manufacturer of the prescription diabetes medication Avandia, must produce dozens of documents that it withheld on claims of privilege.
What has the greatest impact on survival rates of oral cancer? Radiation? Chemotherapy? Perhaps surgery? The truth is none of these; rather, it is the point in time at which the disease is discovered.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that it has received an opinion on its Marketing Authorisation Application (MAA) for Glybera as a potential therapy for Lipoprotein Lipase Deficiency.
The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated the benefit of biomarker tests to support the decision for or against adjuvant systemic chemotherapy in certain breast cancer patients, that is, women with primary hormone receptor-positive, HER2-negative breast cancer and up to 3 affected lymph nodes.
› Verified 1 days ago
Mrs. Renae D Gossett, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 Chesnut Byp, Centre, AL 35960 Phone: 256-927-8050 Fax: 256-927-7166 | |
Amanda Everett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1950 W Main St, Centre, AL 35960 Phone: 256-927-9911 | |
Jared Burt Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Chesnut Byp, Centre, AL 35960 Phone: 256-927-4346 | |
Garry Ray, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Chesnut Byp, Centre, AL 35960 Phone: 256-927-2420 | |
Mr. Jeff Graves, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1490 Chesnut Bypass, Centre, AL 35960 Phone: 256-927-8539 | |
Alana Marie Thompson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1950 W Main St, Centre, AL 35960 Phone: 256-927-9911 |